Xilinx

FBR Capital Markets has published a research report on Semiconductor Trading, in which it writes "Our latest back-end assembly/test production checks suggest 1Q production will seasonally decrease by about 6.5% QOQ, worse than our month-ago checks of –6.0% QOQ and in line with typical seasonality....

Credit Suisse is raising its PT on Xilinx, Inc. (NASDAQ: XLNX) to $31 from $25. “We lower CY11 rev/EPS est. to $2.38bn/$2.22 from $2.42bn/$2.31 vs. Street's $2.33bn/$2.09,” Credit Suisse writes. “Our TP goes to $31 from $25 reflecting a 14.0x multiple on CY11 EPS, in-line with its 2 yr avg of 14.7x...

J.P. Morgan is maintaining its Xilinx, Inc. (NASDAQ: XLNX) F11 revenue estimate of $2.35 billion but raises its F11 EPS estimate from $2.23 to $2.30 due to higher gross margins and a lower tax rate. “We are maintaining our F12 revenue estimate of $2.46 billion but lowering our F12 EPS estimate from...

JP Morgan has raised the price target on Xilinx (NASDAQ: XLNX) from $27 to $29.50 and maintains its Neutral rating.

Xilinx, Inc. (NASDAQ: XLNX) is trading up 0.90% after hours. Shares closed at $31.02; in the after hours market, shares are trading for $31.30. Earlier today, announced third quarter fiscal 2011 sales of $567.2 million, down 8% sequentially and up 10% from the third quarter of the prior fiscal year...

Jefferies & Company has published a research report on Xilinx Corporation (NASDAQ: XLNX) after the company reported some slight share loss and lowered 4Q revenue guidance. In the report, Jefferies writes "Xilinx after market close yesterday lowered its CQ4 revenue guidance to 7-9% Q/Q ($564-...

Yesterday after the close, Xilinx, Inc. (NASDAQ: XLNX) lowered its F3Q11 revenue guidance from a range of flat to down 4% QoQ ($594.9-$619.7 million) to a range of down 7% to 9% QoQ ($563.9-$576.3 million), “in line with our estimate of down 8% QoQ ($570.0 million) but below Consensus of down 2%...

Xilinx Corporation (NASDAQ: XLNX) reported sales below estimates by the Street and Goldman Sachs in its 3Q, and subsequently Goldman Sachs has reiterated its Sell rating. In the report, Goldman Sachs writes "Xilinx reported 3QCY2010 sales of $620mn (+4% qoq), below GS and the Street estimates at $...

Auriga USA has initiated coverage for the following companies: Altera Corporation (NASDAQ: ALTR) price target: $34 Xilinx, Inc. (NASDAQ: XLNX) price target: $29

Barclays Capital analyst Tim Luke reiterated his Overweight rating for shares of Xilinx, Inc. (Nasdaq: XLNX), with a price target of $28, after attending the company's annual analyst day event. The Barclays Capital analyst was impressed by Xilinx's improved margins and growth rates. Luke raised his...